Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital, Caen
Region Stockholm
Beth Israel Deaconess Medical Center
Assistance Publique - Hôpitaux de Paris
Brain Inflammation Collaborative
University of Pittsburgh
Massachusetts General Hospital
Second Affiliated Hospital of Wenzhou Medical University
Assistance Publique Hopitaux De Marseille
M.D. Anderson Cancer Center
University of North Carolina, Chapel Hill
Nordsjaellands Hospital
ProgenaBiome
Takeda
Weill Medical College of Cornell University
Pfizer
Centre Hospitalier Universitaire, Amiens
Janssen Research & Development, LLC
Rambam Health Care Campus
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
IRCCS San Raffaele
Institut du Cancer de Montpellier - Val d'Aurelle
Janssen Scientific Affairs, LLC
University of California, San Diego
University of California, San Diego
University Hospital, Toulouse
University Medical Center Groningen
Luventix, Inc.
VitaMed Research LLC
Takeda
Sanguine Biosciences
Sanguine Biosciences
Assistance Publique - Hôpitaux de Paris
Viome
Global Healthy Living Foundation
University of Saskatchewan
Hospital Galdakao-Usansolo
Centre Hospitalier Universitaire de Saint Etienne
University of Basel
The University of Texas Medical Branch, Galveston
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Alliance Foundation Trials, LLC.
Assistance Publique - Hôpitaux de Paris
Université de Sherbrooke
Radboud University Medical Center
Hospices Civils de Lyon
OMNI Medical Services, LLC
University Hospitals Cleveland Medical Center
Kantonsspital Winterthur KSW